POLB — Poolbeg Pharma Share News
0.000.00%
- £32.07m
- £22.11m
REG - Poolbeg Pharma PLC - POLB 001 LPS Challenge Trial Paper Published
AnnouncementREG - Poolbeg Pharma PLC - Exercise of Options & Total Voting Rights
AnnouncementRCS - Poolbeg Pharma PLC - Letter to Shareholders – 2025 a year of progress
AnnouncementRCS - Poolbeg Pharma PLC - POLB 001 to feature in CRS research programme
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 European Patent granted
AnnouncementREG - Poolbeg Pharma PLC - Interim Results for the six months to 30 June 2025
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 Phase 2a Trial Update
AnnouncementREG - Poolbeg Pharma PLC - Notification of Major Holdings
AnnouncementREG - Poolbeg Pharma PLC - Notification of Major Holdings
AnnouncementREG - AIM - AIM Notice - 25/06/2025
AnnouncementREG - Poolbeg Pharma PLC - Director/PDMR Shareholding
AnnouncementREG - Poolbeg Pharma PLC - Results of GM and AGM Meetings
AnnouncementREG - Poolbeg Pharma PLC - FDA Orphan Drug Designation granted for POLB 001
AnnouncementREG - Poolbeg Pharma PLC - Annual Report, AGM Notice & Circular
AnnouncementREG - Poolbeg Pharma PLC - Result of upsized oversubscribed BookBuild Offer
AnnouncementREG - Poolbeg Pharma PLC - Increase of BookBuild Offer
AnnouncementREG - Poolbeg Pharma PLC - Result of Placing and Notice of General Meeting
AnnouncementREG - Poolbeg Pharma PLC - Proposed Fundraising to raise approximately £4.1M
AnnouncementREG - Poolbeg Pharma PLC - Proposed Retail Offer to raise up to £100,000
Announcement